Massive Upside In Big Money Pharma Favorite?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes in the use of immune therapies for cancer treatment. Specifically, Iovance is exploring new applications of tumor infiltrating lymphocyte (TIL) therapy, utilizing cells that the human body naturally produces to attack cancerous tumors.
There was lots of hype about this next-generation cancer treatment company but its share price has been decidedly lackluster this year, » Read more about: Massive Upside In Big Money Pharma Favorite? »
Read More
Why MongoDB Could Be a Sleeper Stock Ready to Soar
MongoDB is one of those fascinating growth stories that goes back as far as we can see, and we went back a full 5 years.
Each and every quarter showed year-over-year revenue growth. Yet the share price sits at levels similar to those from 4 years ago.
So is MongoDB a buy or a sell?
» Read more about: Why MongoDB Could Be a Sleeper Stock Ready to Soar »
Read More
3 Ways To Protect Against a Market CRASH
With news coming out that Buffett has lightened up on Bank of America, a core holding since 2011, in addition to his sales earlier in the year of his largest equity holding, Apple, concerns are rising that the Oracle of Omaha is reading the tea leaves and seeing gloom on the horizon.
That’s not a surprise given that the so-called Buffett Indicator,
» Read more about: 3 Ways To Protect Against a Market CRASH »
Read More
It Is Too Late To Buy This Pelosi Stock?
What started out as a fun joke tracking Nancy Pelosi’s trades has turned into somewhat of a cult following. That’s because Pelosi’s portfolio was up as high as 71% this year alone but her short-term market outperformance is mirrored over the long-term with returns that rival those of Buffett.
That led many to speculate whether it was time to go all-in when she bought Palo Alto Networks earlier this year.
» Read more about: It Is Too Late To Buy This Pelosi Stock? »
Read More
1 Cloud SaaS Healthcare Stock to Buy on the Dip?
It might surprise many that Veeva Systems Inc. (NYSE:VEEV), best known for its cloud-based software solutions tailored to the life sciences industry, has maintained a core principle of putting customer success and product excellence ahead of short-term gains.
In a market crowded with SaaS companies seeking to serve a wide variety of enterprises,
» Read more about: 1 Cloud SaaS Healthcare Stock to Buy on the Dip? »
Read MoreThe Ivy
Is Buffett Primed To Pounce On a Crash?
In 2024, value investing legend Warren Buffett did the seemingly unthinkable by selling stocks aggressively in a year that saw the S&P 500 climb by about 23 percent.
While the exact figures on Buffett’s selling won’t be known until Berkshire Hathaway releases its Q4 earnings report, the total stood at a staggering $133 billion as of the end of Q3.
» Read more about: Is Buffett Primed To Pounce On a Crash? »
Read MoreThe Spotlight
Is Jessica Alba’s Stock Set For 50% Pop?
The Honest Company (NASDAQ:HNST) is a lifestyle brand most famously associated with founder Jessica Alba that sells a variety of personal care and beauty products, as well as diapers and other baby care products.
It primarily sells online through its own website and other eCommerce channels, though its brand also has a presence in brick-and-mortar retailers.
» Read more about: Is Jessica Alba’s Stock Set For 50% Pop? »
Read MoreThe Daily
Warren Buffett: America's businesses 'usually find a way'
A version of this post first appeared on TKer.co
Warren Buffett, legendary investor and CEO of Berkshire Hathaway (BRK-A), wants everyone to know that he remains a long-term bull on U.S.
» Read more about: Warren Buffett: America's businesses 'usually find a way' »